Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass.
J. Clin. Endocrinol. Metab., Apr;96(4):972-80 (2011)
Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density.
J. Bone Miner. Res., May;25(5):937-47 (2010)
Nonmalignant complications of Paget's disease.
J. Bone Miner. Res., Dec;21 Suppl 2:P64-8 (2006)
Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial.
J. Clin. Endocrinol. Metab., Dec;92(12):4671-7 (2007)
Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.
Contraception., Apr;77(4):239-48 (2008)
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
J. Clin. Endocrinol. Metab., Jun;93(6):2149-57 (2008)
Ten years' experience with alendronate for osteoporosis in postmenopausal women.
N. Engl. J. Med., Mar;350(12):1189-99 (2004)
Intravenous bisphosphonate therapy for osteoporosis: where do we stand?
Curr Osteoporos Rep., Mar;2(1):24-30 (2004)
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.
J. Clin. Endocrinol. Metab., Feb;85(2):720-6 (2000)
Mineral metabolic effects of thyroidectomy and long-term outcomes in a family with MEN 2A.
Henry Ford Hosp. Med. J., 40(3-4):258-60 (1992)
Clinical review 39: Paget's disease of bone.
J. Clin. Endocrinol. Metab., Nov;75(5):1179-82 (1992)
Application of quantitative computed tomography to Paget's disease of bone.
Semin. Arthritis Rheum., Feb;23(4):244-7 (1994)
Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers.
J. Clin. Endocrinol. Metab., Jan;82(1):265-74 (1997)
Diagnosis of the multiglandular endocrine neoplasias.
Clin. Chem., May;36(5):711-8 (1990)
Measurement of regional bone mineral density: a new technique for the evaluation of the temporal bone.
Am J Otol., Sep;14(5):455-9 (1993)
Hearing loss in Paget's disease of bone: evidence of auditory nerve integrity.
Am J Otol., Jan;16(1):27-33 (1995)
Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey.
Surgery., Dec;128(6):1013-20;discussion 1020-1 (2000)
The future of osteoporosis diagnosis and therapy.
Ann. Ital. Med. Int., 7(3 Suppl):166S-170S (1992)
Hearing loss in Paget's disease of bone: the relationship between pure-tone thresholds and mineral density of the cochlear capsule.
Hear. Res., Mar;83(1-2):114-20 (1995)
Improved adherence with PTH(1-84) in an extension trial for 24Â months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis.
Osteoporos Int., Aug (2012)